FDA Seeks Input on Generative AI Medical Device Rules
Silver Spring, Maryland, August 18, 2026 The U.S. Food and Drug Administration (FDA) has issued a new discussion paper...
AI drug discovery artificial intelligence Autoimmune Disease biologics Biomarkers biopharma Biopharmaceuticals Biotechnology Bispecific Antibody Cancer Immunotherapy Cancer Research cancer therapy Cell Therapy Clinical Development Clinical Research clinical trial clinical trials Digital Health drug development Drug Discovery EMA FDA fda approval FDA clearance Gene Therapy Healthcare Innovation healthcare technology immunology Immunotherapy Medical Devices MedTech Monoclonal Antibody Neurodegenerative Disease Neurology Oncology Orphan Drug Phase 1 trial Phase 2 Trial Phase 3 Phase 3 trial Precision Medicine Precision Oncology rare disease Regenerative Medicine targeted therapy
.Gov for New Therapy
Silver Spring, Maryland, August 18, 2026 The U.S. Food and Drug Administration (FDA) has issued a new discussion paper...
Bethesda, Maryland, August 5, 2026 The National Institutes of Health (NIH), through the National Cancer Institute (NCI) and its...
RICHMOND, Va., July 20, 2026 Virginia’s Advanced Pharmaceutical Manufacturing (APM) Tech Hub has secured a $15.97 million investment from...
WASHINGTON, July 17, 2026 The American Pharmacists Association (APhA) has called on the U.S. Food and Drug Administration (FDA)...
WASHINGTON, D.C., July 14, 2026 A coalition of leading public health organizations, pediatricians, and parents has filed a federal...
SILVER SPRING, Maryland, July 10, 2026 The U.S. Food and Drug Administration (FDA) has proposed a new rule designed...
NEW HAVEN, Conn., July 6, 2026 Invivyd announced that the U.S. Food and Drug Administration (FDA) has issued a...
SILVER SPRING, Md., June 29, 2026 The U.S. Food and Drug Administration (FDA) has announced the selection of seven...
NAIROBI, Kenya / KAMPALA, Uganda, June 19, 2026 African health leaders, government officials, clinicians, patient advocates, and international partners...
SILVER SPRING, Md., May 20, 2026 The U.S. Food and Drug Administration (FDA) has intensified its enforcement efforts against...
